Anteris Technologies
Jason Quill is an accomplished leader in the medical device industry with extensive experience in research and development, particularly in transcatheter valve technologies. Currently serving as Vice President of Research and Development at Anteris Technologies since June 2020, Jason has previously held multiple significant roles, including TAVR Sr. Program Director and Senior Project Manager. At AtriCure, Inc. from May 2017 to June 2020, Jason managed new product development for minimally invasive ablation devices and oversaw cross-functional teams across multiple geographies. Prior experience at Medtronic, spanning from July 2009 to May 2017, included serving as a Principal Scientist on key projects such as the Intrepid Transcatheter Mitral Valve Replacement and the CoreValve Transcatheter Aortic Valve. Jason holds a PhD in Biomedical Engineering from the University of Minnesota and a Bachelor of Science in Mechanical Engineering from Purdue University.
This person is not in any teams
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology